AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2016
Feb 19, 2016
34117_dirs_2016-02-19_aeeed52e-3411-4761-a4ba-391b61771fb3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ITUS Corp (ITUS)
CIK: 0000715446
Period of Report: 2016-02-18
Reporting Person: JOHNSON BRUCE F (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-02-18 | Employee Stock Options (Right to Buy) | $2.92 | A | 12000 | Acquired | 2026-02-18 | Common Stock (12000) | Direct |
Footnotes
F1: Right-To-Buy, pursuant to the ITUS Corporation 2010 Share Incentive Plan.
F2: The option vests in four (4) equal installments on each March 31, 2016, June 30, 2016, September 30, 2016 and December 31, 2016.
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6